Key points are not available for this paper at this time.
The MTD for E7107 using this schedule is 4.0 mg/m(2). Pharmacokinetics is dose-dependent and reproducible within patients. Pharmacodynamic analysis revealed dose-dependent reversible inhibition of pre-mRNA processing of target genes, confirming proof-of-principle activity of E7107.
Building similarity graph...
Analyzing shared references across papers
Loading...
Ferry A.L.M. Eskens
Erasmus MC
Francisco Javier Ramos
VA Caribbean Healthcare System
Herman Burger
Erasmus MC
Clinical Cancer Research
Universitat Autònoma de Barcelona
Building similarity graph...
Analyzing shared references across papers
Loading...
Eskens et al. (Tue,) studied this question.
synapsesocial.com/papers/69d84395ba18484428d18920 — DOI: https://doi.org/10.1158/1078-0432.ccr-13-0485